Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19 [PDF]
Summary: Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to the angiotensin-converting enzyme 2 (ACE2) receptor, a critical component of the kallikrein-kinin system.
Caroline P. Martens +28 more
doaj +2 more sources
Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system [PDF]
Background The kallikrein-kinin system is a key regulatory cascade involved in blood pressure maintenance, hemostasis, inflammation and renal function. Currently, approved drugs remain limited to the rare disease hereditary angioedema.
Petra Wisniewski +2 more
doaj +2 more sources
Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity [PDF]
COVID-19 has emerged as a devastating disease in the last 2 years. Many authors appointed to the importance of kallikrein-kinin system (KKS) in COVID-19 pathophysiology as it is involved in inflammation, vascular homeostasis, and coagulation.
Enrique Alfaro +17 more
doaj +2 more sources
Interrelation among exercise training, cardiac hypertrophy, and tissue kallikrein-kinin system in athlete and non-athlete women [PDF]
Introduction: The tissue kallikrein-kinin system is an endogenous homeostatic pathway, which its stimulation is associated with cardioprotection. The present study aimed to determine the effect of exercise training on plasma tissue kallikrein (TK) and ...
Behnam Heidari +4 more
doaj +2 more sources
Modulation of the Plasma Kallikrein-Kinin System Proteins Performed by Heparan Sulfate Proteoglycans [PDF]
Human plasma kallikrein-kinin system proteins are related to inflammation through bradykinin. In the proximity of its target cells, high molecular weight kininogen (H-kininogen) is the substrate of plasma kallikrein, which releases bradykinin from H ...
Guacyara Motta, Ivarne L. S. Tersariol
doaj +2 more sources
Role of the kallikrein–kinin system in traumatic brain injury [PDF]
Traumatic brain injury (TBI) is a major cause of mortality and morbidity worldwide. Despite improvements in acute intensive care, there are currently no specific therapies to ameliorate the effects of TBI. Successful therapeutic strategies for TBI should
Christiane eAlbert-Weissenberger +4 more
doaj +2 more sources
Garadacimab for the long-term prophylaxis of hereditary angioedema. [PDF]
Summary Hereditary angioedema (HAE), a rare and debilitating disease characterized by recurrent and spontaneous attacks of tissue swelling, has a high unmet therapeutic need, with many patients experiencing insufficient disease control with current prophylactic treatments.
Aygören-Pürsün E +5 more
europepmc +2 more sources
Garadacimab zur Langzeitprophylaxe bei hereditärem Angioödem [PDF]
Zusammenfassung Das hereditäre Angioödem (Hereditary angioedema, HAE), eine seltene und belastende Erkrankung, die durch rezidivierende und spontane Gewebeschwellungsattacken gekennzeichnet ist, weist einen hohen ungedeckten therapeutischen Bedarf auf, da Patienten unter aktuellen prophylaktischen Behandlungen eine unzureichende Krankheitskontrolle ...
Aygören‐Pürsün E +5 more
europepmc +2 more sources
Editorial: Kallikrein-kinin system: insights into a multifunctional system [PDF]
Guacyara Motta +2 more
doaj +2 more sources
Ex vivo bradykinin as a functional biomarker for angioedema with normal C1-inhibitor [PDF]
Background: Bradykinin-mediated angioedema (AE-BK) remains diagnostically challenging particularly in patients with normal C1-inhibitor, where diagnosis primarily relies on clinical criteria. Routine laboratory tests can identify complement deficiency in
Jinguo Chen, MD +6 more
doaj +2 more sources

